A carregar...

Cross-Presenting XCR1(+) Dendritic Cells as Targets for Cancer Immunotherapy

The use of dendritic cells (DCs) to generate effective anti-tumor T cell immunity has garnered much attention over the last thirty-plus years. Despite this, limited clinical benefit has been demonstrated thus far. There has been a revival of interest in DC-based treatment strategies following the re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Audsley, Katherine M., McDonnell, Alison M., Waithman, Jason
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140519/
https://ncbi.nlm.nih.gov/pubmed/32121071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030565
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!